Prospective non-interventional observational trial in HIV positiv patients with low level viremia under antiretroviral treatment in real life
- Conditions
- B24Unspecified human immunodeficiency virus [HIV] disease
- Registration Number
- DRKS00011160
- Lead Sponsor
- mib-Dienstleistungs-GmbH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 5000
Inclusion Criteria
Patients are recruited from the normal patient pool of the participating practises. The following criteria have to be fulfilled:
• the signed informed consent [
• a documented HIV-1 infection
• age =18
• on ART treatment (it is also sufficient: - to plan an ART in the next three month after inclusion into the study; - short interruptions of ART due to medical indications or drug holidays” of max. 90 days, this is not valued as a stopping of ART.
Exclusion Criteria
• participation in clinical trials
• patient not competent to sign informed consent
• missing of sufficient documentation of parameters in the patients records
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method How often is a therapeutic change in patients on antiretroviral therapy (ART) liable to positive HIV-1 viremia. Therapeutic change is defined by any readjustment of ART.
- Secondary Outcome Measures
Name Time Method